Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1881-1890 of 2869 for cancer

Edit search filters
  1. A Study To Compare Venetoclax With Fulvestrant Vs. Fulvestrant Alone In Women With Locally Advanced Or Metastatic HER2-negative Cancer Who Have Progressed Or Recurred On A CDK4/6 Inhibitor

    Scottsdale/Phoenix, AZ

  2. A Study To Evaluate The Safety And Effectiveness Of Capivasertib + Fulvestrant Versus Placebo + Fulvestrant As Treatment For Locally Advanced (Inoperable) Or Metastatic Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Breast Cancer

    Jacksonville, FL, Rochester, MN

  3. A Study Of Pembrolizumab (MK-3475) Versus Placebo In Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy In The Treatment Of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer

    Rochester, MN

  4. A Study To Find The Recommended Dose For Further Research For VX-970 And Whole Brain Radiation Therapy To Treat Patients With Brain Metastases From Non-Small Cell Lung Cancer

    Jacksonville, FL, Rochester, MN

  5. A Phase 3 Randomized, Placebo-controlled, Double-blind Study Of Niraparib In Combination With Abiraterone Acetate And Prednisone Versus Abiraterone Acetate And Prednisone For Treatment Of Subjects With Metastatic Prostate Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  6. A Study To Assess The Effectiveness, Safety, And Drug/Body Interactions Of Rovalpituzumab For Third-Line And Later Treatment Of Patients With Small Cell Lung Cancer That Has Returned Or Is Resistant To Treatment

    Rochester, MN

  7. Study Of Radium-223 Dichloride Versus Placebo And Hormonal Treatment As Background Therapy In Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer

    Rochester, MN

  8. Study Of Radium-223 Dichloride Versus Placebo And Treatment With Exemestane / Everolimus In Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer

    Rochester, MN

  9. A Study To Assess The Effectiveness And Safety Of UGN-102 As A Primary Chemoablation Agent In Patients With Low Grade Non-Muscle-Invasive Bladder Cancer (LG NMIBC) At Intermediate Risk Of Recurrence

    Scottsdale/Phoenix, AZ

  10. A Study To Compare The Combination Of Navlimetostat (BMS-986504) With Pembrolizumab And Chemotherapy Versus Placebo Plus Pembrolizumab And Chemotherapy In First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer